The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
4-Acetamido-2-((4,4-bis(3-methylthiophen-2-yl)but-3-en-1-yl)(methyl)amino)-N-(2-chlorobenzyl)-butanamide ID: ALA4781266
PubChem CID: 162662801
Max Phase: Preclinical
Molecular Formula: C28H34ClN3O2S2
Molecular Weight: 544.19
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CC(=O)NCCC(C(=O)NCc1ccccc1Cl)N(C)CCC=C(c1sccc1C)c1sccc1C
Standard InChI: InChI=1S/C28H34ClN3O2S2/c1-19-12-16-35-26(19)23(27-20(2)13-17-36-27)9-7-15-32(4)25(11-14-30-21(3)33)28(34)31-18-22-8-5-6-10-24(22)29/h5-6,8-10,12-13,16-17,25H,7,11,14-15,18H2,1-4H3,(H,30,33)(H,31,34)
Standard InChI Key: BYIMWNNOGMXRCA-UHFFFAOYSA-N
Molfile:
RDKit 2D
36 38 0 0 0 0 0 0 0 0999 V2000
3.8207 -4.5583 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
4.6457 -4.5583 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.9025 -3.7741 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2332 -3.2875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5682 -3.7741 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1299 -5.2263 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9504 -5.1410 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.7934 -5.9796 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9875 -6.1457 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9002 -6.9661 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6536 -7.3026 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2062 -6.6901 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
5.6874 -3.5203 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.3764 -5.5915 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4346 -5.8090 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2551 -5.7237 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.7392 -6.3917 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.5598 -6.3064 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.4028 -7.1450 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.0439 -6.9744 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.8962 -5.5531 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.7168 -5.4678 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.4121 -4.8851 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.7075 -7.7277 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.1916 -8.3957 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
10.8760 -4.6358 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.0524 -4.7178 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.3545 -5.3091 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.1774 -5.2277 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.5190 -4.4729 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.0316 -3.7987 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.2105 -3.8836 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.0128 -6.0600 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
8.8552 -9.1489 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.3393 -9.8169 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.0347 -9.2342 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 2 0
3 4 1 0
4 5 2 0
5 1 1 0
2 6 1 0
6 7 2 0
6 8 1 0
8 9 2 0
9 10 1 0
10 11 2 0
11 12 1 0
12 8 1 0
3 13 1 0
9 14 1 0
7 15 1 0
15 16 1 0
16 17 1 0
17 18 1 0
17 19 1 0
18 20 1 0
18 21 1 0
21 22 1 0
21 23 2 0
20 24 1 0
24 25 1 0
22 27 1 0
26 27 1 0
26 28 2 0
28 29 1 0
29 30 2 0
30 31 1 0
31 32 2 0
32 26 1 0
28 33 1 0
25 34 1 0
34 35 2 0
34 36 1 0
M END Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 544.19Molecular Weight (Monoisotopic): 543.1781AlogP: 6.04#Rotatable Bonds: 12Polar Surface Area: 61.44Molecular Species: NEUTRALHBA: 5HBD: 2#RO5 Violations: 2HBA (Lipinski): 5HBD (Lipinski): 2#RO5 Violations (Lipinski): 2CX Acidic pKa: 13.96CX Basic pKa: 8.12CX LogP: 5.62CX LogD: 4.82Aromatic Rings: 3Heavy Atoms: 36QED Weighted: 0.29Np Likeness Score: -0.93
References 1. Zaręba P,Gryzło B,Malawska K,Sałat K,Höfner GC,Nowaczyk A,Fijałkowski Ł,Rapacz A,Podkowa A,Furgała A,Żmudzki P,Wanner KT,Malawska B,Kulig K. (2020) Novel mouse GABA uptake inhibitors with enhanced inhibitory activity toward mGAT3/4 and their effect on pain threshold in mice., 188 [PMID:31901745 ] [10.1016/j.ejmech.2019.111920 ] 2. Zaręba P, Sałat K, Höfner GC, Łątka K, Bajda M, Latacz G, Kotniewicz K, Rapacz A, Podkowa A, Maj M, Jóźwiak K, Filipek B, Wanner KT, Malawska B, Kulig K.. (2021) Development of tricyclic N-benzyl-4-hydroxybutanamide derivatives as inhibitors of GABA transporters mGAT1-4 with anticonvulsant, antinociceptive, and antidepressant activity., 221 [PMID:34015586 ] [10.1016/j.ejmech.2021.113512 ]